Merck (MRK) to acquire Terns (TERN) for USD 53/shr; deal valued at USD 6.7bln and expected to close in Q2 2026

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

China's Gaming Regulator grants license for 130 domestic online games in March and for 3 imported online games in March

German Chemical Industry association schedules press conference as wage discussions approach an agreement

Merck (MRK) to acquire Terns (TERN) for USD 53/shr; deal valued at USD 6.7bln and expected to close in Q2 2026

Newsquawk Daily US Opening News - 25th March 2026

Ukrainian drones damaged oil loading stands, crude oil and petroleum products reservoirs at Russia's port of Ust-Luga

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Context

Merck's acquisition of Terns for $6.7 billion at $53 per share indicates a significant strategic move, likely aimed at enhancing Merck's pipeline in pharmaceuticals and biotechnology. This deal, expected to close in Q2 2026, could potentially shift investor sentiment positively towards Merck, though investors will need to assess the implications for funding and integration risks moving forward.

Related headlines

The feed had this first.

Use the Platform